Clinical:
My research area involves:
-Development of newer agents and combination of newer biologic agents in various kinds of lymphomas. I am principal investigator and sub investigator in many Phase I, II or III clinical trials. My passion is to develop biologic therapies with less toxicities and more effectiveness.
-Survivorship research which involves well being of all lymphoma patients who have been exposed to chemotherapy, radiation therapy or had bone marrow transplant in past.
-Development of blood test to diagnose and monitor lymphoma during and after treatment. This highly sensitive blood test identifies tumor related genes to monitor lymphoma. This test is still in developmental phase but may eliminate need for biopsies in future.
Translational:
-Lymphomas are biologically diverse tumors. Learning about their genetic make up and protein expression help us understand about their biology and develop new targeted and biological treatments. I collaborate with basic scientists and analyze lymphoma biopsies to understand biologic diversity and develop newer therapies.
UAB Lymphoma program:
UABCCC lymphoma program is comprehensive program involving specialists (medical oncology, surgical oncology, radiation oncology, Bone marrow transplant, survivorship and integrative medicine) and great nurses.
Apart from lymphomas, I also see patients with blood cancers (malignant hematology) and blood related disorders (benign hematology).
You can call my clinic (205-934-5077) or office (205-996-8400) for initial consultation, second opinions or clinical trials.
Special Interests:
Lymphoma
Diffuse large B-cell
Follicular lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
Other B-Cell Lymphomas
Agressive Lymphomas
Any kind of skin lymphomas (Cutaneous T cell/B cell lymphomas)
Targeted Therapy
Clinical Trials
Disparity Research
